Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.20.2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Ordinary Shares
IPO
Ordinary Shares
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Retained Earnings
IPO
Private Placement
Total
Balance at beginning of period at Dec. 31, 2018   $ 719     $ 24,281 $ (2,694)     $ 22,306
Balance at beginning of period (in shares) at Dec. 31, 2018   7,187,500              
Increase (Decrease) in Stockholders' Equity                  
Net income (loss)           (13,739)     (13,739)
Balance at end of period at Mar. 31, 2019   $ 719     24,281 (16,433)     8,567
Balance at end of period (in shares) at Mar. 31, 2019   7,187,500              
Balance at beginning of period at Dec. 31, 2018   $ 719     24,281 (2,694)     22,306
Balance at beginning of period (in shares) at Dec. 31, 2018   7,187,500              
Increase (Decrease) in Stockholders' Equity                  
Net income (loss)                 3,076,468
Balance at end of period at Sep. 30, 2019   $ 811     1,925,420 3,073,774     5,000,005
Balance at end of period (in shares) at Sep. 30, 2019   8,110,156              
Balance at beginning of period at Mar. 31, 2019   $ 719     24,281 (16,433)     8,567
Balance at beginning of period (in shares) at Mar. 31, 2019   7,187,500              
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offerings, gross $ 2,875   $ 287,497,125 $ 7,750,000     $ 287,500,000 $ 7,750,000  
Sale of units in initial public offering, gross (in shares) 28,750,000                
Offering costs         (15,075,329)       (15,075,329)
Common stock subject to possible redemption   $ (2,768)     (276,820,572)       (276,823,340)
Common stock subject to possible redemption (in shares)   (27,682,334)              
Net income (loss)           1,640,103     1,640,103
Balance at end of period at Jun. 30, 2019   $ 826     3,375,505 1,623,670     5,000,001
Balance at end of period (in shares) at Jun. 30, 2019   8,255,166              
Increase (Decrease) in Stockholders' Equity                  
Ordinary shares subject to possible redemption   $ (15)     (1,450,085)       (1,450,100)
Ordinary shares subject to possible redemption (in shares)   (145,010)              
Net income (loss)           1,450,104     1,450,104
Balance at end of period at Sep. 30, 2019   $ 811     1,925,420 3,073,774     5,000,005
Balance at end of period (in shares) at Sep. 30, 2019   8,110,156              
Balance at beginning of period at Dec. 31, 2019   $ 800     775,141 4,224,065     5,000,006
Balance at beginning of period (in shares) at Dec. 31, 2019   7,995,127              
Increase (Decrease) in Stockholders' Equity                  
Ordinary shares subject to possible redemption   $ (10)     (775,141) (186,469)     (961,620)
Ordinary shares subject to possible redemption (in shares)   (96,162)              
Net income (loss)           961,618     961,618
Balance at end of period at Mar. 31, 2020   $ 790       4,999,214     5,000,004
Balance at end of period (in shares) at Mar. 31, 2020   7,898,965              
Balance at beginning of period at Dec. 31, 2019   $ 800     775,141 4,224,065     5,000,006
Balance at beginning of period (in shares) at Dec. 31, 2019   7,995,127              
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offering, gross (in shares)   28,750,000              
Net income (loss)                 (120,091)
Balance at end of period at Sep. 30, 2020   $ 801     895,230 4,103,974     5,000,005
Balance at end of period (in shares) at Sep. 30, 2020   8,007,136              
Balance at beginning of period at Mar. 31, 2020   $ 790       4,999,214     5,000,004
Balance at beginning of period (in shares) at Mar. 31, 2020   7,898,965              
Increase (Decrease) in Stockholders' Equity                  
Ordinary shares subject to possible redemption   $ 1       110,219     110,220
Ordinary shares subject to possible redemption (in shares)   11,022              
Net income (loss)           (110,220)     (110,220)
Balance at end of period at Jun. 30, 2020   $ 791       4,999,213     5,000,004
Balance at end of period (in shares) at Jun. 30, 2020   7,909,987              
Increase (Decrease) in Stockholders' Equity                  
Sale of units in initial public offering, gross (in shares)   28,750,000              
Ordinary shares subject to possible redemption   $ 10     895,230 76,250     971,490
Ordinary shares subject to possible redemption (in shares)   97,149              
Net income (loss)           (971,489)     (971,489)
Balance at end of period at Sep. 30, 2020   $ 801     $ 895,230 $ 4,103,974     $ 5,000,005
Balance at end of period (in shares) at Sep. 30, 2020   8,007,136